Next Article in Journal
Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Previous Article in Journal
Parental Attitudes, Motivators and Barriers Toward Children’s Vaccination in Poland: A Scoping Review
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 7 January 2025 07:30 CET Original file -
article xml uploaded. 7 January 2025 07:30 CET Update -
article pdf uploaded. 7 January 2025 07:30 CET Version of Record https://www.mdpi.com/2076-393X/13/1/42/pdf-vor
article supplementary file uploaded. 7 January 2025 07:30 CET - https://www.mdpi.com/2076-393X/13/1/42#supplementary
article html file updated 7 January 2025 07:32 CET Original file -
article xml file uploaded 8 January 2025 09:18 CET Update -
article xml uploaded. 8 January 2025 09:18 CET Update https://www.mdpi.com/2076-393X/13/1/42/xml
article pdf uploaded. 8 January 2025 09:18 CET Updated version of record https://www.mdpi.com/2076-393X/13/1/42/pdf
article html file updated 8 January 2025 09:22 CET Update https://www.mdpi.com/2076-393X/13/1/42/html
Back to TopTop